Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

2.

Insulin action and age. European Group for the Study of Insulin Resistance (EGIR).

Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U.

Diabetes. 1996 Jul;45(7):947-53.

PMID:
8666147
3.

Is insulin really a heart disease risk factor.

Wingard DL, Barrett-Connor EL, Ferrara A.

Diabetes Care. 1995 Sep;18(9):1299-304. Review. No abstract available.

PMID:
8612451
4.

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ.

N Engl J Med. 1996 Apr 11;334(15):952-7.

5.

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al.

Diabetes. 1993 Nov;42(11):1663-72.

PMID:
8405710
6.

Abdominal obesity is associated with insulin resistance and reduced glycogen synthetase activity in skeletal muscle.

Pedersen SB, Børglum JD, Schmitz O, Bak JF, Sørensen NS, Richelsen B.

Metabolism. 1993 Aug;42(8):998-1005.

PMID:
8345824
7.

Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991.

Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL.

JAMA. 1994 Jul 20;272(3):205-11.

PMID:
8022039
8.

How to measure insulin clearance.

Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ.

Diabetes Metab Rev. 1994 Jul;10(2):119-50. Review. No abstract available.

PMID:
7956676
9.

Regional adiposity and morbidity.

Kissebah AH, Krakower GR.

Physiol Rev. 1994 Oct;74(4):761-811. Review. No abstract available.

PMID:
7938225
10.

The effects of weight loss in obese subjects on the thermogenic, metabolic and haemodynamic responses to the glucose clamp.

Webber J, Donaldson M, Allison SP, Fukagawa NK, Macdonald IA.

Int J Obes Relat Metab Disord. 1994 Nov;18(11):725-30.

PMID:
7866471
11.

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

Kolterman OG, Insel J, Saekow M, Olefsky JM.

J Clin Invest. 1980 Jun;65(6):1272-84.

12.

Quantitative aspects of glucose production and metabolism in healthy elderly subjects.

Robert JJ, Cummins JC, Wolfe RR, Durkot M, Matthews DE, Zhao XH, Bier DM, Young VR.

Diabetes. 1982 Mar;31(3):203-11.

PMID:
6759237
14.

Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians.

Bogardus C, Lillioja S, Mott D, Reaven GR, Kashiwagi A, Foley JE.

J Clin Invest. 1984 Mar;73(3):800-5.

15.

Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women.

Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH.

Metabolism. 1984 Jan;33(1):68-75.

PMID:
6361449
16.

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.

Krotkiewski M, Björntorp P, Sjöström L, Smith U.

J Clin Invest. 1983 Sep;72(3):1150-62.

17.

Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.

Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA.

Am J Physiol. 1983 Jun;244(6):E517-27.

PMID:
6344651
18.

Prediction of lean body mass from height and weight.

Hume R.

J Clin Pathol. 1966 Jul;19(4):389-91.

19.

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913.

Ohlson LO, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L, Björntorp P, Tibblin G.

Diabetes. 1985 Oct;34(10):1055-8.

PMID:
4043554
20.

The kinetics of insulin in man. II. Role of the liver.

Ferrannini E, Cobelli C.

Diabetes Metab Rev. 1987 Apr;3(2):365-97. Review. No abstract available.

PMID:
3552527

Supplemental Content

Support Center